Has Ryan Lawrence, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,358 in general payments to Ryan Lawrence, MD across 71 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Lawrence, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Lawrence, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Lawrence, MD

Dermatology · New Orleans, LANPI 1972166593

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,607 of the $3,358 with a category attached, or 77.6%. It is spread thinly across 19 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,636 and has fallen 90.4% since, to $157 in 2025. That places this record below the midpoint for dermatology clinicians in LA, where the typical reported total is $5,293.

$3,358in general payments, 2019–2025

Across 71 payments — averaging $47.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$724
Johnson & Johnson$577
Ortho Dermatologics, A Division Of Bausch Health US, LLC$496
Sun Pharmaceutical Industries Inc.$349
UCB, Inc.$171
Galderma Laboratories, L.p.$145
plus $896 from 13 others

What the payments were for

Food & beverage$2,60778%
Education$75222%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	16	$724
Johnson & Johnson	10	$577
Ortho Dermatologics, A Division Of Bausch Health US, LLC	6	$496
Sun Pharmaceutical Industries Inc.	6	$349
UCB, Inc.	3	$171
Galderma Laboratories, L.p.	2	$145
Boehringer Ingelheim	1	$125
Janssen Scientific Affairs, LLC	1	$123
E.r. Squibb & Sons, L.L.C.	5	$116
Lilly USA, LLC	5	$105
Sanofi	1	$100
Novartis	4	$81
LEO Pharma Inc.	3	$73
Genentech USA, Inc.	2	$45
Helsinn Therapeutics (U.S.), Inc.	2	$37
Regeneron Healthcare Solutions, Inc.	1	$30
Kyowa Kirin, Inc.	1	$22
Amgen	1	$21
Kerecis Limited	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUOBRII$234
SILIQ$234
ARAZLO$234
SPEVIGO$125
Tremfya$123
JUBLIA$120
Rinvoq$118
ALTRENO$114
ILUMYA$110
Cimzia$105

How this compares

$3,358 in reported general payments places this provider in the 35th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$295,168

Medicare patients

808

Services billed

4,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	33	$120,566
Dupixent SyringeDupilumab	15	$55,885
Clobetasol Propionate	103	$4,171
Ketoconazole	152	$2,735
Tacrolimus	27	$2,402
Triamcinolone Acetonide	188	$2,216
Tretinoin	20	$1,249
Betamethasone Dipropionate	27	$1,209
Metronidazole	22	$1,056
Pimecrolimus	11	$995
Fluorouracil	16	$950
Doxycycline Monohydrate	24	$637
Fluocinonide	28	$619
Clindamycin Phosphate	21	$394
Cephalexin	21	$279

Paid to pharmacies, not to this prescriber.

Other dermatology in New Orleans

William ClaiborneNew Orleans$374K
Erin BohNew Orleans$277K
Mara HaseltineNew Orleans$276K
Julie MermilliodNew Orleans$222K
Sarah JacksonNew Orleans$167K
Deirdre HooperNew Orleans$144K
Patricia HickhamNew Orleans$12K
Stephen KlingerNew Orleans$11K
Katherine HolcombMetairie$411K
Blair BuddenLafayette$329K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →